Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid drugs, diuretic agents, non-steroidal anti-inflammatory, steroidal anti-inflammatory drugs, haematinic, and vitamins and minerals. It also provides its products in form of tablets, capsules, liquids, tubes, and injections. The company exports its products. The company was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Metrics to compare | ABPH | Peers Peers - average of corresponding metrics from companies closely matching ABPH: SQURPHARMA, ORIONPHARM, RENATA, SILVAPHL, BEACONPHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABPHPeersSector |
---|---|---|---|---|
P/E Ratio | 181.7x | 8.8x | −0.4x | |
PEG Ratio | −32.20 | −0.54 | 0.00 | |
Price/Book | 56.8x | 0.8x | 2.6x | |
Price / LTM Sales | 7.8x | 2.1x | 2.9x | |
Upside (Analyst Target) | - | 44.7% | 53.5% | |
Fair Value Upside | Unlock | 14.9% | 9.5% | Unlock |